BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2000
View Archived Issues
Company Profile: ProlX Pharmaceuticals
Read More
Millennium to acquire Cambridge Discovery Chemistry
Read More
Pharmacokinetics and pharmacodynamics of selective ETA antagonist examined in humans
Read More
Schering-Plough enters asthma collaboration with Texas Biotechnology
Read More
Methods of differentiating response to INN-00835 and placebo described at CINP congress
Read More
Propranolol may improve disruptive agitation in AD without serious cardiovascular effects
Read More
Cymserine and analogues, potent and selective BChE inhibitors with potential in AD
Read More
Neotrofin as a novel approach to AD discussed at World Alzheimer Congress
Read More
Virax and IDT receive funding from U.S. NIH to develop HIV vaccines
Read More
NIH accelerates development of HIV vaccines
Read More
[18F]-L-829165: a promising PET tracer for the brain NK1 receptor
Read More
AlphaOne enters agreement with Dana-Farber for tumor suppressor gene
Read More
Biological characteristics of A-176120, a potent FPP mimetic with promise as a cancer therapeutic
Read More
Antisense collaboration established by Lorus Therapeutics and AVI BioPharma
Read More
PathoGenesis commences phase I trial of AeroDose TOBI
Read More
Murine and humanized monoclonal antibodies against alphav integrin receptors
Read More
Synthesis, activity and use of new gabapentin-related compounds
Read More
Novo Nordisk presents new heterocyclic inhibitors of factor VIIa-TF activity
Read More
New Yissum compounds useful against oxidative stress or free radical injury
Read More
Tetracycline derivatives with broad indications reported by CollaGenex
Read More
Novel cathepsin K inhibitors and their use in bone disorders patented
Read More
Broad-spectrum antibacterial compounds emerge from Daiichi R&D
Read More
UT researchers patent dibenzofluorene derivatives with cytotoxic activity
Read More
New series under development at Glaxo Wellcome inhibits hepatic ApoB-100 production
Read More
T-20 phase II results highlighted at AIDS Conference
Read More
Genta begins follow-up studies of Genasense combination therapy for prostate cancer
Read More
CV Therapeutics and Fujisawa form CVT-3146 collaboration
Read More